Your browser doesn't support javascript.
loading
New Insights into the Pathogenesis, Risk Factors, and Treatment of Portal Vein Thrombosis in Patients with Cirrhosis.
Nicoara-Farcau, Oana; Soy, Guillem; Magaz, Marta; Baiges, Anna; Turon, Fanny; Garcia-Criado, Angeles; Barrufet, Marta; Burrel, Marta; Hernández-Gea, Virginia; García-Pagán, Juan Carlos.
Afiliação
  • Nicoara-Farcau O; Department of Hepatology, Regional Institute of Gastroenterology and Hepatology "Octavian Fodor," "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Soy G; Liver Unit, Barcelona Hepatic Hemodynamic Laboratory, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi I i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
  • Magaz M; Liver Unit, Barcelona Hepatic Hemodynamic Laboratory, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi I i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
  • Baiges A; Centro de Investigación Biomédica Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Barcelona, Spain.
  • Turon F; Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN-Liver).
  • Garcia-Criado A; Liver Unit, Barcelona Hepatic Hemodynamic Laboratory, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi I i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
  • Barrufet M; Centro de Investigación Biomédica Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Barcelona, Spain.
  • Burrel M; Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN-Liver).
  • Hernández-Gea V; Liver Unit, Barcelona Hepatic Hemodynamic Laboratory, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi I i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
  • García-Pagán JC; Centro de Investigación Biomédica Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Barcelona, Spain.
Semin Thromb Hemost ; 46(6): 673-681, 2020 Sep.
Article em En | MEDLINE | ID: mdl-32820481
ABSTRACT
Portal vein thrombosis (PVT) is a frequent event in patients with cirrhosis regardless of etiology. Notwithstanding the commonality of the problem, the pathophysiology and risk factors for PVT in cirrhosis are largely unknown. The clinical impact of PVT in the natural history of cirrhosis is unclear, indications for PVT treatment are not well defined, and treatment recommendations are based on experts' opinion and consensus only. Therefore, this review aims to summarize current knowledge of mechanisms and risk factors for PVT development and assess the current evidence of PVT management, with a special focus on strategies of anticoagulation and transjugular intrahepatic portosystemic shunt placement.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Trombose Venosa / Cirrose Hepática Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Trombose Venosa / Cirrose Hepática Idioma: En Ano de publicação: 2020 Tipo de documento: Article